Upgrade to SI Premium - Free Trial

Gilead Sciences (GILD) to Submit Filgotinib NDA This Year

July 2, 2019 6:42 AM
Gilead Sciences, Inc. (NASDAQ: GILD) announced that at a recent pre-New Drug Application (NDA) meeting with the U.S. Food and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles